Saturation mutagenesis of twenty disease-associated regulatory elements at single base-pair resolution

[1]  Gregory M. Cooper,et al.  CADD: predicting the deleteriousness of variants throughout the human genome , 2018, Nucleic Acids Res..

[2]  Jun S. Song,et al.  Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner. , 2018, Cancer cell.

[3]  William S. DeWitt,et al.  A Single-Cell Atlas of In Vivo Mammalian Chromatin Accessibility , 2018, Cell.

[4]  L. Chavez,et al.  Dynamic EBF1 occupancy directs sequential epigenetic and transcriptional events in B-cell programming , 2018, Genes & development.

[5]  David J. Arenillas,et al.  JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework , 2017, Nucleic acids research.

[6]  Manolis Kellis,et al.  Chromatin-state discovery and genome annotation with ChromHMM , 2017, Nature Protocols.

[7]  Maitreya J. Dunham,et al.  Variant Interpretation: Functional Assays to the Rescue. , 2017, American journal of human genetics.

[8]  Nadav Ahituv,et al.  Gene Regulatory Elements, Major Drivers of Human Disease. , 2017, Annual review of genomics and human genetics.

[9]  William Stafford Noble,et al.  Segway 2.0: Gaussian mixture models and minibatch training , 2017, bioRxiv.

[10]  Ian C. McDowell,et al.  Transversions have larger regulatory effects than transitions , 2017, BMC Genomics.

[11]  P. Stenson,et al.  The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies , 2017, Human Genetics.

[12]  Mingming Jia,et al.  COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..

[13]  Gao Wang,et al.  The impact of rare variation on gene expression across tissues , 2016, Nature.

[14]  Giorgio Valentini,et al.  A Whole-Genome Analysis Framework for Effective Identification of Pathogenic Regulatory Variants in Mendelian Disease. , 2016, American journal of human genetics.

[15]  A. Siepel,et al.  Fast, scalable prediction of deleterious noncoding variants from functional and population genomic data , 2016, Nature Genetics.

[16]  Dawei Xu,et al.  Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications , 2016, Genes.

[17]  Michael T. McManus,et al.  A systematic comparison reveals substantial differences in chromosomal versus episomal encoding of enhancer activity , 2016, bioRxiv.

[18]  I. Yeh.  Faculty Opinions recommendation of Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. , 2016 .

[19]  Pardis C Sabeti,et al.  Direct Identification of Hundreds of Expression-Modulating Variants using a Multiplexed Reporter Assay , 2016, Cell.

[20]  Jacob C. Ulirsch,et al.  Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits , 2016, Cell.

[21]  Eric S. Lander,et al.  Direct Identification of Hundreds of Expression-Modulating Variants using a Multiplexed Reporter Assay , 2016, Cell.

[22]  M. Sanson,et al.  TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas , 2016, Journal of Neuro-Oncology.

[23]  J. Buxbaum,et al.  A SPECTRAL APPROACH INTEGRATING FUNCTIONAL GENOMIC ANNOTATIONS FOR CODING AND NONCODING VARIANTS , 2015, Nature Genetics.

[24]  Ricardo Villamarín-Salomón,et al.  ClinVar: public archive of interpretations of clinically relevant variants , 2015, Nucleic Acids Res..

[25]  L. Faivre,et al.  Intrafamilial variability of ZRS‐associated syndrome: characterization of a mosaic ZRS mutation by pyrosequencing , 2015, Clinical genetics.

[26]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[27]  J. Shendure,et al.  The origins, determinants, and consequences of human mutations , 2015, Science.

[28]  S. Spiegl-Kreinecker,et al.  Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis. , 2015, Neuro-oncology.

[29]  Matthew C. Canver,et al.  BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis , 2015, Nature.

[30]  O. Troyanskaya,et al.  Predicting effects of noncoding variants with deep learning–based sequence model , 2015, Nature Methods.

[31]  Chibo Hong,et al.  The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer , 2015, Science.

[32]  Benjamin J. Strober,et al.  A method to predict the impact of regulatory variants from DNA sequence , 2015, Nature Genetics.

[33]  Wei Wang,et al.  Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation. , 2015, European journal of cancer.

[34]  P. Flicek,et al.  The Ensembl Regulatory Build , 2015, Genome Biology.

[35]  Colin Campbell,et al.  An integrative approach to predicting the functional effects of non-coding and coding sequence variation , 2015, Bioinform..

[36]  K. Hoang-Xuan,et al.  TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations , 2014, British Journal of Cancer.

[37]  Kevin Y. Yip,et al.  FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer , 2014, Genome Biology.

[38]  S. Humphries,et al.  Functional analysis of four LDLR 5′UTR and promoter variants in patients with familial hypercholesterolaemia , 2014, European Journal of Human Genetics.

[39]  E. Jabs,et al.  A Novel ZRS Mutation Leads to Preaxial Polydactyly Type 2 in a Heterozygous Form and Werner Mesomelic Syndrome in a Homozygous Form , 2014, Human mutation.

[40]  A. Siepel,et al.  Probabilities of Fitness Consequences for Point Mutations Across the Human Genome , 2014, Nature Genetics.

[41]  E. Segal,et al.  In pursuit of design principles of regulatory sequences , 2014, Nature Reviews Genetics.

[42]  E. Zeggini,et al.  Functional annotation of non-coding sequence variants , 2014, Nature Methods.

[43]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[44]  M. Knowles,et al.  Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine. , 2014, European urology.

[45]  Mark I. McCarthy,et al.  Pancreatic islet enhancer clusters enriched in type 2 diabetes risk–associated variants , 2013, Nature Genetics.

[46]  Manolis Kellis,et al.  Systematic discovery and characterization of regulatory motifs in ENCODE TF binding experiments , 2013, Nucleic acids research.

[47]  Theresa Guo,et al.  A Polymorphism in IRF4 Affects Human Pigmentation through a Tyrosinase-Dependent MITF/TFAP2A Pathway , 2013, Cell.

[48]  Matthew C. Canver,et al.  An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level , 2013, Science.

[49]  D. Schadendorf,et al.  TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism , 2013, Proceedings of the National Academy of Sciences.

[50]  Miguel Melo,et al.  Frequency of TERT promoter mutations in human cancers , 2013, Nature Communications.

[51]  Gary L. Gallia,et al.  TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal , 2013, Proceedings of the National Academy of Sciences.

[52]  D. Schadendorf,et al.  TERT Promoter Mutations in Familial and Sporadic Melanoma , 2013, Science.

[53]  Lynda Chin,et al.  Highly Recurrent TERT Promoter Mutations in Human Melanoma , 2013, Science.

[54]  M. Al-Qattan,et al.  A novel mutation in the SHH long‐range regulator (ZRS) is associated with preaxial polydactyly, triphalangeal thumb, and severe radial ray deficiency , 2012, American journal of medical genetics. Part A.

[55]  Shane J. Neph,et al.  Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.

[56]  Joseph B Hiatt,et al.  Massively parallel functional dissection of mammalian enhancers in vivo , 2012, Nature Biotechnology.

[57]  Michael F. Melgar,et al.  Discovery of active enhancers through bidirectional expression of short transcripts , 2011, Genome Biology.

[58]  Heng Li,et al.  A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data , 2011, Bioinform..

[59]  N. Plana,et al.  Functional analysis of LDLR promoter and 5′ UTR mutations in subjects with clinical diagnosis of familial hypercholesterolemia , 2011, Human mutation.

[60]  N. Ahituv,et al.  cis‐regulatory mutations are a genetic cause of human limb malformations , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.

[61]  Takayuki Suzuki,et al.  Identification of spontaneous mutations within the long‐range limb‐specific Sonic hedgehog enhancer (ZRS) that alter Sonic hedgehog expression in the chicken limb mutants oligozeugodactyly and silkie breed , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.

[62]  F. V. van Bockxmeer,et al.  Familial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution , 2011, Critical reviews in clinical laboratory sciences.

[63]  Serafim Batzoglou,et al.  Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++ , 2010, PLoS Comput. Biol..

[64]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[65]  Olle Melander,et al.  From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus , 2010, Nature.

[66]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[67]  S. Ellard,et al.  Novel monogenic diabetes mutations in the P2 promoter of the HNF4A gene are associated with impaired function in vitro , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[68]  Rudolf Grosschedl,et al.  Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin. , 2010, Immunity.

[69]  G. Coetzee,et al.  8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC , 2010, Proceedings of the National Academy of Sciences.

[70]  Jay Shendure,et al.  Parallel, tag-directed assembly of locally derived short sequence reads , 2010, Nature Methods.

[71]  Richard Durbin,et al.  Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..

[72]  N. Tommerup,et al.  Preaxial polydactyly/triphalangeal thumb is associated with changed transcription factor-binding affinity in a family with a novel point mutation in the long-range cis-regulatory element ZRS , 2010, European Journal of Human Genetics.

[73]  D. Wieczorek,et al.  A specific mutation in the distant sonic hedgehog (SHH) cis‐regulator (ZRS) causes Werner mesomelic syndrome (WMS) while complete ZRS duplications underlie Haas type polysyndactyly and preaxial polydactyly (PPD) with or without triphalangeal thumb , 2010, Human mutation.

[74]  Jay Shendure,et al.  High-resolution analysis of DNA regulatory elements by synthetic saturation mutagenesis , 2009, Nature Biotechnology.

[75]  M. Pelizzo,et al.  The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors , 2009, PLoS genetics.

[76]  D. Reich,et al.  Functional Enhancers at the Gene-Poor 8q24 Cancer-Linked Locus , 2009, PLoS genetics.

[77]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[78]  K. Hemminki,et al.  A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer. , 2009, Cancer genetics and cytogenetics.

[79]  J. Carpten,et al.  Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. , 2009, Human molecular genetics.

[80]  Alberto Piazza,et al.  Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants , 2009, Nature Genetics.

[81]  J. Carpten,et al.  Genetic Variants and Family History Predict Prostate Cancer Similar to Prostate-Specific Antigen , 2009, Clinical Cancer Research.

[82]  S E Humphries,et al.  Update and Analysis of the University College London Low Density Lipoprotein Receptor Familial Hypercholesterolemia Database , 2008, Annals of human genetics.

[83]  Ali Amin Al Olama,et al.  Multiple newly identified loci associated with prostate cancer susceptibility , 2008, Nature Genetics.

[84]  W. Willett,et al.  Multiple loci identified in a genome-wide association study of prostate cancer , 2008, Nature Genetics.

[85]  A. Visel,et al.  Ultraconservation identifies a small subset of extremely constrained developmental enhancers , 2008, Nature Genetics.

[86]  Dolores Corella,et al.  Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.

[87]  D. Goldstein,et al.  In vitro assays fail to predict in vivo effects of regulatory polymorphisms. , 2007, Human molecular genetics.

[88]  Peter Almgren,et al.  Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. , 2007, The Journal of clinical investigation.

[89]  Oliver Sieber,et al.  A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 , 2007, Nature Genetics.

[90]  David Reich,et al.  A common genetic risk factor for colorectal and prostate cancer , 2007, Nature Genetics.

[91]  P. Fearnhead,et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.

[92]  Inna Dubchak,et al.  VISTA Enhancer Browser—a database of tissue-specific human enhancers , 2006, Nucleic Acids Res..

[93]  J. Kastelein,et al.  Update of the molecular basis of familial hypercholesterolemia in The Netherlands , 2005, Human mutation.

[94]  Michael C O'Donovan,et al.  Strong bias in the location of functional promoter polymorphisms , 2005, Human mutation.

[95]  D. Haussler,et al.  Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. , 2005, Genome research.

[96]  E. Grice,et al.  A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk , 2005, Nature.

[97]  P. Moi,et al.  A novel silent β‐thalassemia mutation in the distal CACCC box affects the binding and responsiveness to EKLF , 2004, British journal of haematology.

[98]  D. Haussler,et al.  Ultraconserved Elements in the Human Genome , 2004, Science.

[99]  A. Sgourou,et al.  Thalassaemia mutations within the 5′UTR of the human β‐globin gene disrupt transcription , 2004, British journal of haematology.

[100]  P. Toutouzas,et al.  Molecular characterization of familial hypercholesterolemia in German and Greek patients , 2004 .

[101]  F. Nielsen,et al.  Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency. , 2003, Blood.

[102]  M. Eriksson,et al.  Genetic characterization of Swedish patients with familial hypercholesterolemia: a heterogeneous pattern of mutations in the LDL receptor gene. , 2002, Atherosclerosis.

[103]  T. Frayling,et al.  A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young. , 2001, Human molecular genetics.

[104]  V. Máximo,et al.  A new PKLR gene mutation in the R‐type promoter region affects the gene transcription causing pyruvate kinase deficiency , 2000, British journal of haematology.

[105]  A. Marais,et al.  Mutation -59c-->t in repeat 2 of the LDL receptor promoter: reduction in transcriptional activity and possible allelic interaction in a South African family with familial hypercholesterolaemia. , 1999, Human molecular genetics.

[106]  Elaine H. Zackai,et al.  Identification of a Mutation in a GATA Binding Site of the Platelet Glycoprotein Ibβ Promoter Resulting in the Bernard-Soulier Syndrome* , 1996, The Journal of Biological Chemistry.

[107]  P. Reitsma,et al.  Hemophilia B Leyden: substitution of thymine for guanine at position -21 results in a disruption of a hepatocyte nuclear factor 4 binding site in the factor IX promoter. , 1993, Blood.

[108]  P. Reitsma,et al.  Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[109]  K. Sykes,et al.  A naturally occurring gamma globin gene mutation enhances SP1 binding activity , 1990, Molecular and cellular biology.

[110]  F. Collins,et al.  Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin , 1988, Molecular and cellular biology.

[111]  C. Luo,et al.  A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes. , 1985, Molecular biology and evolution.

[112]  D. E. Bauer,et al.  Growing and Genetically Manipulating Human Umbilical Cord Blood-Derived Erythroid Progenitor (HUDEP) Cell Lines. , 2018, Methods in molecular biology.

[113]  R. T. Lie,et al.  Edinburgh Research Explorer Disruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lip , 2018 .

[114]  Wayne M Patrick,et al.  Error-prone PCR and effective generation of gene variant libraries for directed evolution. , 2014, Methods in molecular biology.

[115]  Martin Kircher,et al.  Analysis of high-throughput ancient DNA sequencing data. , 2012, Methods in molecular biology.

[116]  John C Chaput,et al.  Random mutagenesis by error-prone PCR. , 2010, Methods in molecular biology.

[117]  K. Pollard,et al.  Detection of nonneutral substitution rates on mammalian phylogenies. , 2010, Genome research.

[118]  A. Bowcock,et al.  Two novel point mutations in the long‐range SHH enhancer in three families with triphalangeal thumb and preaxial polydactyly , 2007, American journal of medical genetics. Part A.

[119]  R. Galetto,et al.  A mutation (-49C>T) in the promoter of the low density lipoprotein receptor gene associated with familial hypercholesterolemia. , 2002, Journal of lipid research.